Progyny Inc

$24.27
(as of Jul 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Progyny Inc

Stock Price
$24.27
Ticker Symbol
PGNY
Exchange
NASDAQ

Industry Information for Progyny Inc

Sector
Healthcare
Industry
Healthcare Plans

Company Description for Progyny Inc

Country
USA
Full Time Employees
675

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Fundamentals for Progyny Inc

Market Capitalization
$1,839,508,224
EBITDA
$76,669,000
Dividends per Share
P/E Ratio
37.65
Forward P/E Ratio
13.76
Earnings per Share
$0.57
Earnings per Share Estimate Next Year
Profit Margin
4.33%
Shares Outstanding
85,718,000
Percent Owned by Insiders
7.64%
Percent Owned by Institutions
98.36%
52-Week High
52-Week Low

Technical Indicators for Progyny Inc

50-Day Moving Average
200-Day Moving Average
RSI
69
0.88

Analyst Ratings for Progyny Inc

Strong Buy
4
Buy
0
Hold
6
Sell
0
Strong Sell
0

News About Progyny Inc

Jul 8, 2025, 3:52 PM EST
Health care stocks rose late Tuesday afternoon with the NYSE Health Care Index gaining 0.4% and the See more.
Jul 8, 2025, 1:28 PM EST
Recursion Pharmaceuticals (RXRX) climbed about 12% after Tuesday saying it acquired full interest in See more.
Jul 8, 2025, 11:55 AM EST
Investing.com - Leerink Partners upgraded Progyny (NASDAQ:PGNY) from Market Perform to Outperform on Tuesday, maintaining a price target of $28.00, which represents approximately 9x CY26 EV/EBITDA. See more.
Jul 8, 2025, 11:54 AM EST
Investing.com - Progyny (NASDAQ:PGNY) stock rose after BofA Securities maintained its Buy rating and $30.00 price target on the fertility benefits management company. See more.